Tranexamic acid toxicity in human periarticular tissues. Issue 1 (January 2019)

• Record Type: Journal Article
• Authors: McLean, M.; McCall, K.; Smith, I. D. M.; Blyth, M.; Kitson, S. M.; Crowe, L. A. N.; Leach, W. J.; Rooney, B. P.; Spencer, S. J.; Mullen, M.; Campton, J. L.; McInnes, I. B.; Akbar, M.; Millar, N. L.
• Is Part Of: Bone & joint research. Volume 8:Issue 1(2019)
• Page Start: 11
• Page End: 18
• Publication Date: 2019-01
• Subjects: Tranexamic acid -- Apoptosis -- Periarticular tissues -- Tendon -- Cartilage -- Synovium; Musculoskeletal system -- Periodicals; 573.705
• DOI: 10.1302/2046-3758.81.BJR-2018-0181.R1
• Languages: English
• ISSNs: 2046-3758

Abstract

Abstract : Objectives: Tranexamic acid (TXA) is an anti-fibrinolytic medication commonly used to reduce perioperative bleeding. Increasingly, topical administration as an intra-articular injection or perioperative wash is being administered during surgery. Adult soft tissues have a poor regenerative capacity and therefore damage to these tissues can be harmful to the patient. This study investigated the effects of TXA on human periarticular tissues and primary cell cultures using clinically relevant concentrations. Methods: Tendon, synovium, and cartilage obtained from routine orthopaedic surgeries were used for ex vivo and in vitro studies using various concentrations of TXA. The in vitro effect of TXA on primary cultured tenocytes, fibroblast-like synoviocytes, and chondrocytes was investigated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) cell viability assays, fluorescent microscopy, and multi-protein apoptotic arrays for cell death. Results: There was a significant (p < 0.01) increase in cell death within all tissue explants treated with 100 mg/ml TXA. MTT assays revealed a significant (p < 0.05) decrease in cell viability in all tissues following treatment with 50 mg/ml or 100 mg/ml of TXA within four hours. There was a significant (p < 0.05) increase in cell apoptosis after one hour of exposure to TXA (100 mg/ml) in all tissues. Conclusion: The current study demonstrates that TXA caused significant periarticular tissue toxicity ex vivo and in vitro at commonly used clinical concentrations. Cite this article : M. McLean, K. McCall, I. D. M. Smith, M. Blyth, S. M. Kitson, L. A. N. Crowe, W. J. Leach, B. P. Rooney, S. J. Spencer, M. Mullen, J. L. Campton, I. B. McInnes, M. Akbar, N. L. Millar. Tranexamic acid toxicity in human periarticular tissues. Bone Joint Res 2019;8:11–18. DOI: 10.1302/2046-3758.81.BJR-2018-0181.R1.